Cross-tabulation of pre- and postoperative diagnosis for patients treated with pancreatoduodenectomy restricted to patients with a solid tumour preoperatively
| Postoperative diagnosis . | PDAC N = 1239 . | dCCA N = 247 . | AC N = 331 . | DC N = 142 . | Endocrine cancer/metastases from other cancers N = 62 . | Premalignant/benign N = 213 . | Other N = 40 . |
|---|---|---|---|---|---|---|---|
| Preoperative diagnosis | |||||||
| PDAC N = 1380 | 1059 (76.7) | 99 (7.2) | 55 (4.0) | 13 (0.9) | 50 (3.6) | 92 (6.7) | 12 (0.9) |
| dCCA N = 370 | 114 (30.8) | 133 (36.0) | 47 (12.7) | 3 (0.8) | 5 (1.4) | 55 (14.9) | 13 (3.5) |
| AC N = 322 | 44 (13.7) | 13 (4.0) | 200 (62.1) | 19 (5.9) | 1 (0.3) | 40 (12.4) | 5 (1.6) |
| DC N = 202 | 22 (10.9) | 2 (1.0) | 29 (14.4) | 107 (53.0) | 6 (3.0) | 26 (12.9) | 10 (5.0) |
| Postoperative diagnosis . | PDAC N = 1239 . | dCCA N = 247 . | AC N = 331 . | DC N = 142 . | Endocrine cancer/metastases from other cancers N = 62 . | Premalignant/benign N = 213 . | Other N = 40 . |
|---|---|---|---|---|---|---|---|
| Preoperative diagnosis | |||||||
| PDAC N = 1380 | 1059 (76.7) | 99 (7.2) | 55 (4.0) | 13 (0.9) | 50 (3.6) | 92 (6.7) | 12 (0.9) |
| dCCA N = 370 | 114 (30.8) | 133 (36.0) | 47 (12.7) | 3 (0.8) | 5 (1.4) | 55 (14.9) | 13 (3.5) |
| AC N = 322 | 44 (13.7) | 13 (4.0) | 200 (62.1) | 19 (5.9) | 1 (0.3) | 40 (12.4) | 5 (1.6) |
| DC N = 202 | 22 (10.9) | 2 (1.0) | 29 (14.4) | 107 (53.0) | 6 (3.0) | 26 (12.9) | 10 (5.0) |
Data are presented as absolute number (percentage). The percentage in the cells is the preoperative diagnosis concordance with postoperative histopathological diagnosis. The concordance ratio for each cancer type is highlighted in bold. AC, ampullary cancer; dCCA, distal cholangiocarcinoma; DC, duodenal cancer; PDAC, pancreatic ductal adenocarcinoma.
Cross-tabulation of pre- and postoperative diagnosis for patients treated with pancreatoduodenectomy restricted to patients with a solid tumour preoperatively
| Postoperative diagnosis . | PDAC N = 1239 . | dCCA N = 247 . | AC N = 331 . | DC N = 142 . | Endocrine cancer/metastases from other cancers N = 62 . | Premalignant/benign N = 213 . | Other N = 40 . |
|---|---|---|---|---|---|---|---|
| Preoperative diagnosis | |||||||
| PDAC N = 1380 | 1059 (76.7) | 99 (7.2) | 55 (4.0) | 13 (0.9) | 50 (3.6) | 92 (6.7) | 12 (0.9) |
| dCCA N = 370 | 114 (30.8) | 133 (36.0) | 47 (12.7) | 3 (0.8) | 5 (1.4) | 55 (14.9) | 13 (3.5) |
| AC N = 322 | 44 (13.7) | 13 (4.0) | 200 (62.1) | 19 (5.9) | 1 (0.3) | 40 (12.4) | 5 (1.6) |
| DC N = 202 | 22 (10.9) | 2 (1.0) | 29 (14.4) | 107 (53.0) | 6 (3.0) | 26 (12.9) | 10 (5.0) |
| Postoperative diagnosis . | PDAC N = 1239 . | dCCA N = 247 . | AC N = 331 . | DC N = 142 . | Endocrine cancer/metastases from other cancers N = 62 . | Premalignant/benign N = 213 . | Other N = 40 . |
|---|---|---|---|---|---|---|---|
| Preoperative diagnosis | |||||||
| PDAC N = 1380 | 1059 (76.7) | 99 (7.2) | 55 (4.0) | 13 (0.9) | 50 (3.6) | 92 (6.7) | 12 (0.9) |
| dCCA N = 370 | 114 (30.8) | 133 (36.0) | 47 (12.7) | 3 (0.8) | 5 (1.4) | 55 (14.9) | 13 (3.5) |
| AC N = 322 | 44 (13.7) | 13 (4.0) | 200 (62.1) | 19 (5.9) | 1 (0.3) | 40 (12.4) | 5 (1.6) |
| DC N = 202 | 22 (10.9) | 2 (1.0) | 29 (14.4) | 107 (53.0) | 6 (3.0) | 26 (12.9) | 10 (5.0) |
Data are presented as absolute number (percentage). The percentage in the cells is the preoperative diagnosis concordance with postoperative histopathological diagnosis. The concordance ratio for each cancer type is highlighted in bold. AC, ampullary cancer; dCCA, distal cholangiocarcinoma; DC, duodenal cancer; PDAC, pancreatic ductal adenocarcinoma.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
